Craven House Capital PLC Portfolio Update (9177R)

TIDMCRV

RNS Number : 9177R

Craven House Capital PLC

03 March 2023

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

Craven House Capital plc

Portfolio Update

Craven House Capital plc ("Craven House" or the "Company"), the AIM quoted investment company provides this update regarding the following investee companies:

Stormfjord Ltd ("Stormfjord")

The Company has been informed that Stormfjord, the owner of www.onebas.com raised $100,000 on 1st March 2023 at a valuation of $28,000,000.

Craven House originally acquired a 29.9% stake in Onebas.com Ltd (the previous legal entity under which the domain Onebas.com was owned) on 13 March 2020 for a consideration of $1,600,000 via a share subscription for 800,000 ordinary shares in the Company priced at $10.00 per share. This valued Onebas.com Ltd at $5.35m.

Following completion of the fundraising, Craven House's holding of 29,900,000 shares represents 25.5% of Stomfjord.

Rosedog Ltd ("Rosedog")

The Company has been informed that Rosedog, the owner of www.tvzinos.com raised $70,000 on 1st March 2023 at a valuation of $28,000,000.

Craven House originally acquired a 29.9% stake in Rosedog on 13 March 2020 for a consideration of $1,600,000 via a share subscription for 800,000 ordinary shares in the Company priced at $10.00 per share. This valued Rosedog Ltd at $5.35m.

Following completion of the fundraising, Craven House's holding of 29,900,000 shares represents 28.6% of Rosedog.

Bio Vitos Ltd ("Bio Vitos")

The Company has been informed that Bio Vitos raised $13,000 on 1st March 2023, at a valuation of $10,000,000.

Craven House originally acquired a 29.9% stake in Bio Vitos (previously called YRRO Ltd) on 13 March 2020 for a consideration of $1,600,000 via a share subscription for 800,000 ordinary shares in the Company priced at $10.00 per share. This valued Bio Vitos at $5.35m.

Following completion of the fundraising, Craven House's holding of 14,708,700 shares represents 24.5% of Bio Vitos.

Ends

For further information please contact:

 
 Craven House Capital Plc          Tel: [phone] 
 Mark Pajak 
 www.Cravenhousecapital.com 
 Tel: [phone] 
 
 SI Capital                        Tel: [phone] 
 Broker 
 Nick Emerson 
 www.sicapital.co.uk 
 
 SPARK Advisory Partners Limited   Tel: [phone] 
 Nominated Adviser 
 Matt Davis/James Keeshan 
 www.Sparkadvisorypartners.com 
 

About Craven House Capital plc: The Company's Investing Policy is primarily to invest in or acquire a portfolio of companies, partnerships, joint ventures, businesses or other assets participating in the e-Commerce sector.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

PFUBIGDXSBGDGXX

(END) Dow Jones Newswires

March 03, 2023 13:15 ET (18:15 GMT)